Post-Traumatic Stress Disorder (PTSD) Clinical Trial
Official title:
THE PRISM-PTSD PILOT TRIAL (Process-Instructed Self Neuro-Modulation ("Prism") Pilot Trial for Post-Traumatic Stress Disorder)
A Prospective, Single-Arm, Open-Label Pilot Trial, to Assess Safety and Effectiveness of Process-Instructed Self neuro-Modulation ("Prism"), as an Adjunct to Standard of Care, in Subjects with Post-Traumatic Stress Disorder (PTSD)
Prism is a software device intended for neurofeedback (NF) training (i.e. operant condition based on EEG signals, also known as EEG-biofeedback), to be used in combination with a standard computer and supported EEG hardware. For purposes of this training, information for feedback is derived and processed from several EEG channels. Prism provides visual and/or auditory signals that correspond to the patient's computed EEG signal, which serves as a surrogate indicator of achieving a state of reduced amygdala activity. The study is a Prospective, Single-Arm, Open-Label Pilot Trial, to Assess Safety and Effectiveness of Process-Instructed Self neuro-Modulation ("Prism"), as an Adjunct to Standard of Care, in Subjects with Post-Traumatic Stress Disorder (PTSD). The study population will include subjects diagnosed with Post-Traumatic Stress Disorder (PTSD) from 1 year to 20 years after index trauma. The total expected enrollment is up to 100 subjects in one or more sites. The study's primary objective is to assess the safety and effectiveness of fifteen (15) EEG-NF training sessions using the Prism software in reducing PTSD-related symptoms. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT05189977 -
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
|
Phase 1 | |
| Completed |
NCT01806168 -
rTMS in the Treatment of PTSD
|
N/A | |
| Not yet recruiting |
NCT06194851 -
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
|
Phase 2 | |
| Completed |
NCT02187224 -
Progesterone Effect on Individuals Diagnoses With AD and PTSD.
|
Phase 2/Phase 3 | |
| Completed |
NCT02549508 -
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
|
N/A | |
| Not yet recruiting |
NCT01940549 -
Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder
|
N/A | |
| Completed |
NCT02012738 -
Treatment of Trauma and Violence in the Townships of South Africa
|
N/A | |
| Not yet recruiting |
NCT06419959 -
NightWare and Cardiovascular Health in Veterans With PTSD
|
N/A | |
| Terminated |
NCT03209882 -
Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
| Recruiting |
NCT05407337 -
The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme
|
N/A | |
| Completed |
NCT02030522 -
Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma
|
N/A | |
| Completed |
NCT01729325 -
Prevention of Post-Traumatic Stress Disorder in Soldiers
|
Phase 2 | |
| Completed |
NCT02053532 -
Functional Brain Imaging in PTSD
|
N/A | |
| Not yet recruiting |
NCT02598024 -
Treating Earthquake in Nepal Trauma (TENT) Trial 2016
|
N/A | |
| Terminated |
NCT02237703 -
Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)
|
N/A | |
| Withdrawn |
NCT02356861 -
LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans
|
N/A | |
| Not yet recruiting |
NCT05974631 -
Evaluating Treatments for Suicidal Veterans With PTSD
|
N/A | |
| Not yet recruiting |
NCT06288594 -
TraumaRelief App: A Pilot RCT Assessing Feasibility and Acceptability
|
N/A | |
| Completed |
NCT01847469 -
Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence
|
Phase 2 | |
| Completed |
NCT01691092 -
PET Imaging of mGLuR5 With Drug Challenge
|
N/A |